In the recent guidelines, ApoB analysis is recommended as a tool for risk assessment, particularly for patients with high TG levels, diabetes, obesity, metabolic syndrome, or very low LDL-C levels. The gene discussed is APOB; the disease is obesity due to melanocortin 4 receptor deficiency.